Device Trial Radar · NCT06282614
Performance and Safety of MUCOGYNE® Ovule as a Moisturizer
Last checked: Nov 20, 2026Latest source record: Apr 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
33
Actual
Start
Apr 11, 2024
Primary completion
Feb 14, 2025
Study completion Feb 14, 2025
Sponsor
- Lead sponsor
- BiocodexNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Voisin Consulting Life Science (VCLS)
- First posted
- Feb 28, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this post-Market Clinical Follow-up (PMCF) study is to confirm the efficacy and safety of MUCOGYNE® Ovule in the maintainance of natural moisture of the vulvovaginal mucosa and in the compensation for any natural secretions deficiencies, when used in accordance with its approved labeling, in the context of vulvovaginal dryness.
Conditions
- Vaginal Dryness
Interventions
Mucogyne OvuleDevice
At inclusion visit (V0), the Investigator will ask the subject to use MUCOGYNE® Ovule 2 times a week until symptoms improve during 5 weeks (D35± 3) preferably at bedtime
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of the efficacy of MUCOGYNE® Ovule intra vaginal applications on subjects' vaginal dryness irrespective of the cause over a 35-day period of useTime frame: Day 0 to Day 35 ± 3
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
JEAN Christian's medical office
Nogent-sur-Marne, France
Dr Raïssa APERANO-MAS's medical office
Rennes, France
Dr Ramez GHADRI's medical office
Orléans, France, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.